0
     

Report Added
Report already added
Nuclear Medicine Market in India - Industry Outlook and Forecast 2020-2026

Nuclear Medicine Market in India - Industry Outlook and Forecast 2020-2026

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide._x000D_
_x000D_
This report contains market size and forecasts of Nuclear Medicine in India, including the following market information:_x000D_
India Nuclear Medicine Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
Top Five Competitors in India Nuclear Medicine Market 2019 (%)_x000D_
The global Nuclear Medicine market was valued at 5490.7 million in 2019 and is projected to reach US$ 7219.3 million by 2026, at a CAGR of 7.1% during the forecast period. While the Nuclear Medicine market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
COVID-19 pandemic has big impact on Nuclear Medicine businesses, with lots of challenges and uncertainty faced by many players of Nuclear Medicine in India. This report also analyses and evaluates the COVID-19 impact on Nuclear Medicine market size in 2020 and the next few years in India_x000D_
Total Market by Segment:_x000D_
India Nuclear Medicine Market, By Type, 2015-2020, 2021-2026 ($ millions)_x000D_
India Nuclear Medicine Market Segment Percentages, By Type, 2019 (%)_x000D_
Tc-99_x000D_
I-123/131_x000D_
In-111_x000D_
Xe-133_x000D_
Th-201_x000D_
Ga-67_x000D_
Other_x000D_
_x000D_
India Nuclear Medicine Market, By Application, 2015-2020, 2021-2026 ($ millions)_x000D_
India Nuclear Medicine Market Segment Percentages, By Application, 2019 (%)_x000D_
Diagnostic_x000D_
Therapeutic_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Nuclear Medicine Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Nuclear Medicine Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
GE Healthcare_x000D_
Bracco Imaging_x000D_
Mallinckrodt_x000D_
Lantheus Medical Imaging_x000D_
Bayer_x000D_
Triad Isotopes_x000D_
Nordion_x000D_
Jubilant Pharma_x000D_
Eli Lilly_x000D_
SIEMENS_x000D_
China Isotope & Radiation_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Nuclear Medicine Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 COVID-19 Impact: India Nuclear Medicine Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 India Nuclear Medicine Overall Market Size_x000D_
2.1 India Nuclear Medicine Market Size: 2020 VS 2026_x000D_
2.2 India Nuclear Medicine Revenue, Prospects & Forecasts: 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Nuclear Medicine Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Nuclear Medicine Companies Ranked by Revenue_x000D_
3.3 India Nuclear Medicine Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 Top 3 and Top 5 Nuclear Medicine Companies in India, by Revenue in 2019_x000D_
3.5 India Manufacturers Nuclear Medicine Product Type_x000D_
3.6 Tier 1, Tier 2 and Tier 3 Nuclear Medicine Players in India_x000D_
3.6.1 List of India Tier 1 Nuclear Medicine Companies_x000D_
3.6.2 List of India Tier 2 and Tier 3 Nuclear Medicine Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Nuclear Medicine Market Size Markets, 2020 & 2026_x000D_
4.1.2 Tc-99_x000D_
4.1.3 I-123/131_x000D_
4.1.4 In-111_x000D_
4.1.5 Xe-133_x000D_
4.1.6 Th-201_x000D_
4.1.7 Ga-67_x000D_
4.1.8 Other_x000D_
4.2 By Type - India Nuclear Medicine Revenue & Forecasts_x000D_
4.2.1 By Type - India Nuclear Medicine Revenue, 2015-2020_x000D_
4.2.2 By Type - India Nuclear Medicine Revenue, 2021-2026_x000D_
4.2.3 By Type - India Nuclear Medicine Revenue Market Share, 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Nuclear Medicine Market Size, 2020 & 2026_x000D_
5.1.2 Diagnostic_x000D_
5.1.3 Therapeutic_x000D_
5.2 By Application - India Nuclear Medicine Revenue & Forecasts_x000D_
5.2.1 By Application - India Nuclear Medicine Revenue, 2015-2020_x000D_
5.2.2 By Application - India Nuclear Medicine Revenue, 2021-2026_x000D_
5.2.3 By Application - India Nuclear Medicine Revenue Market Share, 2015-2026_x000D_
6 Players Profiles_x000D_
6.1 GE Healthcare_x000D_
6.1.1 GE Healthcare Corporate Summary_x000D_
6.1.2 GE Healthcare Business Overview_x000D_
6.1.3 GE Healthcare Nuclear Medicine Major Product Offerings_x000D_
6.1.4 GE Healthcare Revenue in India (2015-2020)_x000D_
6.1.5 GE Healthcare Key News_x000D_
6.2 Bracco Imaging_x000D_
6.2.1 Bracco Imaging Corporate Summary_x000D_
6.2.2 Bracco Imaging Business Overview_x000D_
6.2.3 Bracco Imaging Nuclear Medicine Major Product Offerings_x000D_
6.2.4 Bracco Imaging Revenue in India (2015-2020)_x000D_
6.2.5 Bracco Imaging Key News_x000D_
6.3 Mallinckrodt_x000D_
6.3.1 Mallinckrodt Corporate Summary_x000D_
6.3.2 Mallinckrodt Business Overview_x000D_
6.3.3 Mallinckrodt Nuclear Medicine Major Product Offerings_x000D_
6.3.4 Mallinckrodt Revenue in India (2015-2020)_x000D_
6.3.5 Mallinckrodt Key News_x000D_
6.4 Lantheus Medical Imaging_x000D_
6.4.1 Lantheus Medical Imaging Corporate Summary_x000D_
6.4.2 Lantheus Medical Imaging Business Overview_x000D_
6.4.3 Lantheus Medical Imaging Nuclear Medicine Major Product Offerings_x000D_
6.4.4 Lantheus Medical Imaging Revenue in India (2015-2020)_x000D_
6.4.5 Lantheus Medical Imaging Key News_x000D_
6.5 Bayer_x000D_
6.5.1 Bayer Corporate Summary_x000D_
6.5.2 Bayer Business Overview_x000D_
6.5.3 Bayer Nuclear Medicine Major Product Offerings_x000D_
6.5.4 Bayer Revenue in India (2015-2020)_x000D_
6.5.5 Bayer Key News_x000D_
6.6 Triad Isotopes_x000D_
6.6.1 Triad Isotopes Corporate Summary_x000D_
6.6.2 Triad Isotopes Business Overview_x000D_
6.6.3 Triad Isotopes Nuclear Medicine Major Product Offerings_x000D_
6.6.4 Triad Isotopes Revenue in India (2015-2020)_x000D_
6.6.5 Triad Isotopes Key News_x000D_
6.7 Nordion_x000D_
6.6.1 Nordion Corporate Summary_x000D_
6.6.2 Nordion Business Overview_x000D_
6.6.3 Nordion Nuclear Medicine Major Product Offerings_x000D_
6.4.4 Nordion Revenue in India (2015-2020)_x000D_
6.7.5 Nordion Key News_x000D_
6.8 Jubilant Pharma_x000D_
6.8.1 Jubilant Pharma Corporate Summary_x000D_
6.8.2 Jubilant Pharma Business Overview_x000D_
6.8.3 Jubilant Pharma Nuclear Medicine Major Product Offerings_x000D_
6.8.4 Jubilant Pharma Revenue in India (2015-2020)_x000D_
6.8.5 Jubilant Pharma Key News_x000D_
6.9 Eli Lilly_x000D_
6.9.1 Eli Lilly Corporate Summary_x000D_
6.9.2 Eli Lilly Business Overview_x000D_
6.9.3 Eli Lilly Nuclear Medicine Major Product Offerings_x000D_
6.9.4 Eli Lilly Revenue in India (2015-2020)_x000D_
6.9.5 Eli Lilly Key News_x000D_
6.10 SIEMENS_x000D_
6.10.1 SIEMENS Corporate Summary_x000D_
6.10.2 SIEMENS Business Overview_x000D_
6.10.3 SIEMENS Nuclear Medicine Major Product Offerings_x000D_
6.10.4 SIEMENS Revenue in India (2015-2020)_x000D_
6.10.5 SIEMENS Key News_x000D_
6.11 China Isotope & Radiation_x000D_
6.11.1 China Isotope & Radiation Corporate Summary_x000D_
6.11.2 China Isotope & Radiation Nuclear Medicine Business Overview_x000D_
6.11.3 China Isotope & Radiation Nuclear Medicine Major Product Offerings_x000D_
6.11.4 China Isotope & Radiation Revenue in India (2015-2020)_x000D_
6.11.5 China Isotope & Radiation Key News_x000D_
6.12 Dongcheng_x000D_
6.12.1 Dongcheng Corporate Summary_x000D_
6.12.2 Dongcheng Nuclear Medicine Business Overview_x000D_
6.12.3 Dongcheng Nuclear Medicine Major Product Offerings_x000D_
6.12.4 Dongcheng Revenue in India (2015-2020)_x000D_
6.12.5 Dongcheng Key News_x000D_
_x000D_
7 Key Market Trends & Influences 2021-2026_x000D_
7.1 PESTLE Analysis for India Nuclear Medicine Market_x000D_
7.2 Market Opportunities & Trends_x000D_
7.3 Market Drivers_x000D_
7.4 Market Restraints_x000D_
_x000D_
8 Conclusion_x000D_
_x000D_
9 Appendix_x000D_
9.1 Note_x000D_
9.2 Examples of Clients_x000D_
9.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Nuclear Medicine in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Nuclear Medicine Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Nuclear Medicine Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Nuclear Medicine Sales by Companies, (K Units), 2015-2020_x000D_
Table 6. India Nuclear Medicine Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Nuclear Medicine Price (2015-2020) (US$/Unit)_x000D_
Table 8. India Manufacturers Nuclear Medicine Product Type_x000D_
Table 9. List of India Tier 1 Nuclear Medicine Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Nuclear Medicine Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Nuclear Medicine Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Nuclear Medicine Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Nuclear Medicine Sales in India (K Units), 2015-2020_x000D_
Table 14. By Type - Nuclear Medicine Sales in India (K Units), 2021-2026_x000D_
Table 15. By Application - Nuclear Medicine Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Nuclear Medicine Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Nuclear Medicine Sales in India, (K Units), 2015-2020_x000D_
Table 18. By Application - Nuclear Medicine Sales in India, (K Units), 2021-2026_x000D_
Table 19. GE Healthcare Corporate Summary_x000D_
Table 20. GE Healthcare Nuclear Medicine Product Offerings_x000D_
Table 21. GE Healthcare Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 22. Bracco Imaging Corporate Summary_x000D_
Table 23. Bracco Imaging Nuclear Medicine Product Offerings_x000D_
Table 24. Bracco Imaging Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 25. Mallinckrodt Corporate Summary_x000D_
Table 26. Mallinckrodt Nuclear Medicine Product Offerings_x000D_
Table 27. Mallinckrodt Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 28. Lantheus Medical Imaging Corporate Summary_x000D_
Table 29. Lantheus Medical Imaging Nuclear Medicine Product Offerings_x000D_
Table 30. Lantheus Medical Imaging Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 31. Bayer Corporate Summary_x000D_
Table 32. Bayer Nuclear Medicine Product Offerings_x000D_
Table 33. Bayer Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 34. Triad Isotopes Corporate Summary_x000D_
Table 35. Triad Isotopes Nuclear Medicine Product Offerings_x000D_
Table 36. Triad Isotopes Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 37. Nordion Corporate Summary_x000D_
Table 38. Nordion Nuclear Medicine Product Offerings_x000D_
Table 39. Nordion Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 40. Jubilant Pharma Corporate Summary_x000D_
Table 41. Jubilant Pharma Nuclear Medicine Product Offerings_x000D_
Table 42. Jubilant Pharma Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 43. Eli Lilly Corporate Summary_x000D_
Table 44. Eli Lilly Nuclear Medicine Product Offerings_x000D_
Table 45. Eli Lilly Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 46. SIEMENS Corporate Summary_x000D_
Table 47. SIEMENS Nuclear Medicine Product Offerings_x000D_
Table 48. SIEMENS Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 49. China Isotope & Radiation Corporate Summary_x000D_
Table 50. China Isotope & Radiation Nuclear Medicine Product Offerings_x000D_
Table 51. China Isotope & Radiation Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
Table 52. Dongcheng Corporate Summary_x000D_
Table 53. Dongcheng Nuclear Medicine Product Offerings_x000D_
Table 54. Dongcheng Nuclear Medicine Revenue (US$, Mn), (2015-2020)_x000D_
List of Figures_x000D_
Figure 1. Nuclear Medicine Segment by Type_x000D_
Figure 2. Nuclear Medicine Segment by Application_x000D_
Figure 3. India Nuclear Medicine Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Nuclear Medicine Market Size in India, (US$, Mn): 2020 VS 2026_x000D_
Figure 6. India Nuclear Medicine Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. The Top 3 and 5 Players Market Share by Nuclear Medicine Revenue in 2019_x000D_
Figure 8. By Type - India Nuclear Medicine Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 9. By Type - India Nuclear Medicine Market Share, 2015-2026_x000D_
Figure 10. By Application - Nuclear Medicine Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 11. By Application - India Nuclear Medicine Market Share, 2015-2026_x000D_
Figure 12. PEST Analysis for India Nuclear Medicine Market in 2020_x000D_
Figure 13. Nuclear Medicine Market Opportunities & Trends in India_x000D_
Figure 14. Nuclear Medicine Market Drivers in India_x000D_

Kindly Fill The Form Below

Report Title: Nuclear Medicine Market in India - Industry Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW